Laura Bessen
Directeur/Bestuurslid bij C4 THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Laura Bessen is an Independent Director at C4 Therapeutics, Inc. and Artiva Biotherapeutics, Inc. She previously worked as the Vice President & Head-US Medical at Bristol Myers Squibb Co. Dr. Bessen holds an undergraduate degree from the State University of New York at Binghamton and a doctorate degree from New York University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
-.--% | 23-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Laura Bessen
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Bestuurslid | 29-07-2022 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 03-03-2022 |
Eerdere bekende functies van Laura Bessen
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Laura Bessen
| New York University School of Medicine | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| C4 THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |